Vista Pharmaceuticals News

Vista Pharma accepts CS Barkha Jain resignation

Vista Pharmaceuticals Ltd accepted the resignation of Mrs. Barkha Jain as Company Secretary and Compliance Officer effective September 4, 2026. The Board noted her services as she pursues other opportunities.

Vista Pharmaceuticals reports FY26 net loss of ₹1,206.12 lakh

Vista Pharmaceuticals reported a net loss of ₹1,206.12 lakh for FY26, widening from ₹464.87 lakh in FY25. Revenue from operations fell to ₹539.95 lakh from ₹1,007.46 lakh.

Vista Pharmaceuticals Board Meeting on May 29

Vista Pharmaceuticals Limited will hold a board meeting on May 29, 2026, to consider audited financial results for FY26.

Vista Pharmaceuticals Files Q4 FY26 Compliance Cert

Vista Pharmaceuticals Limited submitted its quarterly compliance certificate under SEBI regulations for dematerialization processes for the quarter ended 31.03.2026, confirming adherence to regulatory requirements.

Vista Pharmaceuticals Reports Q3 FY26 Loss of ₹231.94 Lakhs

Vista Pharmaceuticals posted a net loss of ₹231.94 lakhs for Q3 FY26, widening from ₹132.23 lakhs in Q3 FY25. Revenue declined to ₹241.82 lakhs from ₹255.50 lakhs year-on-year.